| Literature DB >> 35215726 |
Aristeidis Papagiannopoulos1, Konstantinos Sotiropoulos2.
Abstract
Polysaccharides are natural polymers with hydrophilic, biocompatible and biodegradable characteristics and have many opportunities in the food and pharmaceutical sectors. This review focuses on the field of nano and microstructures whose internal structure is based on networked polysaccharide chains in 3D i.e., polysaccharide nanogels (NGs) and microgels (MGs). As it is observed the number of articles on NGs and MGs in peer reviewed scientific journals has been increasing over the last two decades. At the same time, the relative contribution of polysaccharides in this field is gaining place. This review focuses on the different applied methods for the fabrication of a variety of polysaccharide-based NGs and MGs and aims to highlight the recent advances on the subject and present their potentials and properties with regards to their integration in aspects of medicinal and food sciences. The presentation of the recent advances in the application of polysaccharide NGs and MGs is divided in materials with potential as emulsion stabilizers and materials with potential as carriers of bioactives. For applications in the medical sector the division is based on the fabrication processes and includes self-assembled, electrostatically complexed/ionically crosslinked and chemically crosslinked NGs and MGs. It is concluded that many advances are expected in the application of these polysaccharide-based materials and in particular as nutrient-loaded emulsion stabilizers, viscosity modifiers and co-assembled structures in combination with proteins.Entities:
Keywords: drug delivery; emulsion stabilization; microgels; nanogels; nutraceutical delivery; polysaccharides; proteins
Year: 2022 PMID: 35215726 PMCID: PMC8963082 DOI: 10.3390/polym14040813
Source DB: PubMed Journal: Polymers (Basel) ISSN: 2073-4360 Impact factor: 4.329
Figure 1Chemical structure of chitosan (a), hyaluronic acid (b), alginate (c), anthocyanins (general structure) (d), curcumin in the enol (e1) and keto (e2) form and (f) doxorubicin. In d R1 and R2 can be H, OH or OCH3 and R3 can be 3-O-glucoside.
Figure 2(a) Published articles in peer-reviewed journals on NGs (black) and polysaccharide-based NGs (grey). (b) Ratio of articles on polysaccharide-based NGs over articles on NGs (source: Scopus).
Figure 3(a) Published articles in peer-reviewed journals on MGs (black) and polysaccharide-based MGs (grey). (b) Ratio of articles on polysaccharide-based MGs over articles on MGs (source: Scopus).
Examples of MGs/NGs as oil-in-water emulsion stabilizers.
| Polysaccharide | Size | Formation Mechanism | Ref. |
|---|---|---|---|
| Chitosan | NG | Amide bonding with stearic acid (EDC-mediated reaction) | [ |
| NG | Crosslinking with genipin | [ | |
| MG | Crosslinking with genipin | [ | |
| Chitosan/carboxymethyl starch | NG | Amide bonding with stearic acid (EDC-mediated reaction) | [ |
| Chitosan/Myristic acid | NG | Amide bonding(EDC-mediated reaction) | [ |
| Whey protein/dextran | MG | Maillard conjugation, top-down method | [ |
| Pectin | MG | Crosslinking with CaCl2 | [ |
| Pectin | MG | Crosslinking with CaCl2 | [ |
| Cyclodextrin | NG | Crosslinking with 1,4-phenylene diisocyanate (PDI) | [ |
Figure 4Mechanisms of emulsion destabilization. © 2021 Arantzazu Santamaria-Echart, Isabel P. Fernandes, Samara C. Silva, Stephany C. Rezende, Giovana Colucci, Madalena M. Dias and Maria Filomena Barreiro. Originally published in [28] under the terms of the Creative Commons Attribution 3.0 License. Available from: 10.5772/intechopen.99892.
Figure 5Ellulose microgel at the oil-water surface and oil droplets in water protected by microgel particles. Reprinted from [32].
Examples of MGs/NGs as encapsulation carriers of nutraceuticals.
| Polysaccharide | Size | Crosslinking Method | Loaded Substance | Potential for Applications | Ref. |
|---|---|---|---|---|---|
| Alginate | MG | Emulsification/internal gelation, Polyelectrolyte complexes (Chitosan-Chondroitin sulfate) | Anthocyanins | Controlled delivery | [ |
| MG | CaCl2 crosslinking | Rutin, tiliroside, β-carotene, curcumin | Therapeutic | [ | |
| Pectin | NG | Ionic gelation with sodium tripolyphosphate | Resveratrol | Ocular treatments | [ |
| NG | Covalent bonding with citrate | Green tea | Antioxidant activity | [ | |
| MG | Ionotropic gelation, CaCl2 crosslinking |
| Storage stability enhancement, protected delivery | [ | |
| Carboxymethyl konjac glucomannan/chitosan | NG | Covalent bonding, | Curcumin | Controlled release | [ |
| Soy polysaccharide | NG | Self-assembly with Soy protein | Folic acid | Controlled release, protected delivery | [ |
| Hyaluronic acid | MG | Enzymatic crosslinking of tyramine conjugated | Lysozyme, TGF-β1 | Sustained release | [ |
| Chitosan | NG | Ionic gelation with sodium tripolyphosphate | Fucoxanthin | Controlled release, Storage stability enhancement | [ |
| Chit/Alginate | MG | Electrostatic interactions | Sustained release | [ |
Figure 6Ormation of cross-linked CMKG/Chit nanogels and release profile of free curcumin and encapsulated curmumin in ucrosslinked/crosslinked nanogels under simulated gastrointestinal conditions. CMKG: carboxymethyl konjac glucomannan, CS: Chit. Reprinted from [49], Copyright (2021), with permission from Elsevier.
Examples of polysaccharide NGs with applications in medical sciences.
| Polysaccharide | Formation Mechanism | Loaded Substance | Potential for Applications | Ref. |
|---|---|---|---|---|
| Hyaluronic acid | crosslinking by glycerol diglycidyl ether in emulsion | 3 ((E) 3 (4 hydroxyphenyl)acryloyl) 2H chromen 2 one | Blood compatibility, loading and release in biological fluids | [ |
| electrostatic complexation with keratin and crosslinking by peroxide | DOX | Antitumor activity | [ | |
| Self-assembled by DEGMA side chains and coumarin | paclitaxel | Activity against ovarian cancer cells | [ | |
| Disulfide bonds by methacrylating with cystamine | Cationic DOX | Glioma therapy | [ | |
| electrostatic complexation with poly-l-lysine | GFP, DOX and VAN | chemotherapy and antibiotic activity | [ | |
| radical polymerization of | DOX and Au nanoclusters | tumor cell inhibition | [ | |
| electrostatic complexation with Fbg and thermal treatment | Curcumin | therapeutic and diagnostic | [ | |
| Chondroitin sulfate | Self-assembling grafted by octadecylamine | Curcumin | Activity against human breast cancer cells | [ |
| Self-assembly by conjugated prednisolone | Prednisolone | treatment of ulcerative colitis | [ | |
| Self-assembly by conjugated prednisolone | Prednisolone | Treatment of rheumatoid arthritis | [ | |
| self-assembly by conjugated methotrexate | Methotrexate | activity against A549T and Hela tumor cells | [ | |
| electrostatic complexation with BSA and thermal treatment | β-Carotene | Therapeutic | [ | |
| Chitosan | grafted phenylamine for host-guest interaction in the presence cucurbit[8]uril | DOX | Hindering the growth of human lung cancer cells | [ |
| Ionic gelation with tripolyphosphate | Honey | Effect of laponite on drug loading/release | [ | |
| Ionic gelation with tripolyphosphate and enzymatic by peroxide | 5-Fluorouracil | Effect of crosslinking and pH conditions on drug release | [ | |
| Alginate | Crosslinking by CaCl2 | Ovalbumin | Dendritic cell targeting | [ |
| Self-assembly by conjugated prednisolone | Prednisolone | Arthritis therapy | [ | |
| ionic crosslinking with gadolinium in reverse microemulsion | Hydrophilic drugs and rhodamine b | Treatment of neurodegenerative diseases and MRI | [ | |
| disulfide modification and CaCl2 crosslinking | DOX and superparamagnetic iron oxide NPs | chemotherapy and MRI | [ | |
| CaCl2 crosslinking | DOX and GL | treatment of hepatocellular carcinoma | [ | |
| Pullulan | Physical crosslinking by conjugated cholesterol units | Insulin | Tongue muscle regeneration | [ |
| crosslinked with terminal thiol group polyethylene glycol | Human dermal fibroblasts/osteoblasts | Osteogenic NG transplants | [ | |
| Physical crosslinking by conjugated cholesterol units | Ovalbumin | Anticancer immunotherapy | [ | |
| electrostatic complexation with fucoidan and genipin crosslinking | miRNA | Atherothrombosis treatment | [ | |
| κ-Carrageenan/Chitosan | copolymerization of acrylamide and sodium acrylate | Rivastigmine | Biocompatibility, drug release, incorporation of carbon dots | [ |
| carboxymethyl cellulose | electrostatic complexation with BSA and thermal treatment | Camptothecin, 132I | Therapeutic and diagnostic action | [ |
| Xanthan gum | electrostatic complexation with BSA and thermal treatment | Curcumin | Therapeutic | [ |
| Dextran | thermal treatment with lysozyme | DOX and Au NPs | Optical cell imaging and cancer treatment | [ |
Examples of polysaccharide MGs with applications in medical sciences.
| Polysaccharide | Formation Mechanism | Loaded Substance | Potential for Applications | Ref. |
|---|---|---|---|---|
| Hyaluronic acid | Fe3+ and Gd3+ crosslinking in reverse micelle emulsion medium | Fe and Gd | Blood contacting applications and MRI signal enhancers | [ |
| Crosslinikng by divinyl sulfone | VAN | Sustainable drug delivery | [ | |
| Alginate/Chondroitin sulfate/Silk fibroin | Droplet microfluidics and Ca2+/Zn2+ crosslinking | PS NPs and BSA-coated PS NPs | Controlled release of drug-loaded NPs | [ |
| Chitosan | Schiff-base crosslinking reaction | BSA and AgSD | Wound dressings | [ |
| Schiff-base crosslinking reaction | BSA | Pulmonary drug delivery | [ | |
| Emulsion polymerization | vitamin-B12 | Oral drug delivery | [ | |
| Alginate | microspheres crosslinking by CaCl2 | RPMI 8226 cells | Model for drug resistance in multiple myeloma | [ |
| metal ions crosslinked hydrogel and microfluidic preparation | mesenchymal stem cells | Microenvironment for osteogenesis | [ | |
| chemically bonded interpenetrating hydrogels with HA and squeezing | Human umbilical vein/mouse aortic endothelial cells | Tissue regeneration | [ | |
| crosslinking by CaCl2 in a microfluidic device | Bone marrow mesenchymal stem cells | Scaffolds for bone regeneration | [ | |
| Dextran | Schiff base reaction with diamine in w/o inverse emulsion | magnetic NPs and DOX | DOX release | [ |
Figure 7Self-assembly of a polysaccharide in aqueous medium driven by associative units along its backbone.
Figure 8Cytotoxicity of curcumin (Cur)-loaded NGs and free curcumin om MCF-7 cells (human breast cancer). The bars indicate which two groups are being compared. The single asterisks denote statistically significant difference with p-value < 0.05. Reprinted from [72], Copyright (2020), with permission from Elsevier.
Figure 9Formation of NGs/MGs by electrostatic complexation of oppositely charged polysaccharides (a) and by ionic crosslinking with a divalent metal cation (b).
Figure 10Preparation of the double-crosslinked and DOX-loaded FK/HA NGs. FK: feather keratin, HA: hyaluronic acid, DOX: doxorubicin. Reprinted from [66], Copyright (2020), with permission from Elsevier.
Figure 11DOX release from DOX-loaded iron-oxide/Alg nanoparticles in (a) PBS and (b) redox-triggered release by GSH. SPION: superparamagnetic iron oxide nanoparticles, AlgSS: disulfide bond modified Alg. Reprinted from [84], Copyright (2019), with permission from Elsevier.
Figure 12Preparation of a polysaccharide NG or MG with chemical crosslinking.
Figure 13Scanning electron microscopy on Alg and Alg-sucrose hydrogels. Reprinted from [65], Copyright (2019), with permission from Elsevier.